Turaga, Ravi Chakra http://orcid.org/0000-0001-9075-7645
Satyanarayana, Ganesh
Sharma, Malvika
Yang, Jenny J. http://orcid.org/0000-0002-2310-7658
Wang, Shiyuan
Liu, Chunfeng
Li, Sun
Yang, Hua
Grossniklaus, Hans http://orcid.org/0000-0003-0178-9712
Farris, Alton Brad http://orcid.org/0000-0001-5534-7763
Gracia-Sancho, Jordi
Liu, Zhi-Ren
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA217482)
Article History
Received: 4 June 2020
Accepted: 26 August 2021
First Online: 16 September 2021
Competing interests
: Z.-R.L. holds shares in the company ProDa BioTech LLC, which licensed the rights to commercialize ProAgio. L.S. holds shares in the company Amoytop Biotech Co. Ltd. which licensed the rights to commercialize ProAgio in China. The remaining authors declare no competing financial and personal interests.